Medical Marijuana Commission
September 23, 2022
10:00 a.m.
Room 3

* Agenda Revised September 20, 2022, 12:19 pm *
Revision Notes: Added item #1.


  BLUE = already considered.   RED = currently being considered.   BLACK = not yet considered.
 **Click on an instrument for additional information.  Click on an author for the author's home page.




 (1) Discussion regarding changes to the law pursuant to Act 491 of the 2022 Regular Session
 (2) Receive updates from the Louisiana Department of Health relative to the transition of the program pursuant to Act 491 of the 2022 Regular Session
 (3) Receive updates from the Louisiana Department of Agriculture and Forestry relative to the testing of products
 (4) Receive updates from the Louisiana Board of Pharmacy relative to license expansion pursuant to Act 491 of the 2022 Regular Session



Persons who do not feel comfortable giving testimony in person at this time may submit a prepared statement in accordance with House Rule 14.33 in lieu of appearing before the committee:

A. Any interested person or any committee member may file with the committee a prepared statement concerning a specific instrument or matter under consideration by the committee or concerning any matter within the committee's scope of authority, and the committee records shall reflect receipt of such statement and the date and time thereof.

B. Any person who files a prepared statement which contains data or statistical information shall include in such prepared statement sufficient information to identify the source of the data or statistical information. For the purposes of this Paragraph, the term "source" shall mean a publication, website, person, or other source from which the data or statistical information contained in the prepared statement was obtained by the person or persons who prepared the statement.

NOTE: Statements emailed to and received prior to noon on Thursday, September 22, 2022, will be distributed to the committee members prior to the meeting.

All persons desiring to participate in the meeting shall utilize appropriate protective health measures and observe the recommended and appropriate social distancing.